Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryotaro Nakamura

Showing results (71-80 of 244) with videos related to

Pageof 25
Sort By:
Haematologica|August 10, 2014
Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantationSung-Yong Kim, Jennifer Le Rademacher, Joseph H Antin, et al.
Blood Advances|July 25, 2018
Prediction of cardiovascular disease among hematopoietic cell transplantation survivorsSaro H Armenian, Dongyun Yang, Jennifer Berano Teh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2022
Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic MicroangiopathySamer K Khaled, Kathleen Claes, Yeow Tee Goh, et al.
Blood|June 23, 2023
Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemiaJonathan E Brammer, Karen Ballen, Lubomir Sokol, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2007
Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesisMinoo Battiwalla, Yiyuan Wu, Rajinder P S Bajwa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 7, 2022
Association Between Body Composition and Development of Glucose Intolerance after Allogeneic Hematopoietic Cell TransplantationRusha Bhandari, Jennifer Berano Teh, Tianhui He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 9, 2020
Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials NetworkJohn E Levine, Joseph H Antin, Carl E Allen, et al.
Blood|April 17, 2009
Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipientsWendi Zhou, Jeff Longmate, Simon F Lacey, et al.
Leukemia & Lymphoma|January 2, 2024
Treatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinibDat Ngo, Jose Tinajero, Shanpeng Li, et al.
Haematologica|June 1, 2023
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapyRyotaro Nakamura, Bhavisha A Patel, Soyoung Kim, et al.
Pageof 25

Showing results (71-80 of 244) with videos related to

Sort By:
Pageof 25
Haematologica|August 10, 2014
Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantationSung-Yong Kim, Jennifer Le Rademacher, Joseph H Antin, et al.
Blood Advances|July 25, 2018
Prediction of cardiovascular disease among hematopoietic cell transplantation survivorsSaro H Armenian, Dongyun Yang, Jennifer Berano Teh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2022
Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic MicroangiopathySamer K Khaled, Kathleen Claes, Yeow Tee Goh, et al.
Blood|June 23, 2023
Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemiaJonathan E Brammer, Karen Ballen, Lubomir Sokol, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2007
Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesisMinoo Battiwalla, Yiyuan Wu, Rajinder P S Bajwa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 7, 2022
Association Between Body Composition and Development of Glucose Intolerance after Allogeneic Hematopoietic Cell TransplantationRusha Bhandari, Jennifer Berano Teh, Tianhui He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 9, 2020
Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials NetworkJohn E Levine, Joseph H Antin, Carl E Allen, et al.
Blood|April 17, 2009
Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipientsWendi Zhou, Jeff Longmate, Simon F Lacey, et al.
Leukemia & Lymphoma|January 2, 2024
Treatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinibDat Ngo, Jose Tinajero, Shanpeng Li, et al.
Haematologica|June 1, 2023
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapyRyotaro Nakamura, Bhavisha A Patel, Soyoung Kim, et al.
Pageof 25